Consistently, it did not alter the mRNA levels of cyclin D1 (CCND1) and MYC1 pertinent to cell cycle progression (Figure 4C), suggesting that ODZ10117 affects the viability of glioblastoma cells, but not proliferation. Here, CCND1 is linked to glioblastoma.